A study to use triiodothyronine and other pro inflammatory markers to predict the outcome of congestive cardiac failure
Not Applicable
- Conditions
- Health Condition 1: I509- Heart failure, unspecified
- Registration Number
- CTRI/2022/05/042435
- Lead Sponsor
- DY Patil Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 All known patients of congestive cardiac failure with BNP value more than 400ng/ml.
Exclusion Criteria
1 Pregnant woman
2 Pediatric age group
3 Renal failure
4 Liver cirrohsis
5 Cancer Sepsis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢To assess the role of thyroid hormones and pro-inflammatory markers in the prognosis of patient population with heart failure.Timepoint: at the time of diagnosis <br/ ><br>3 weeks after diagnosis <br/ ><br>6 weeks after diagnosis <br/ ><br>6 months after diagnosis <br/ ><br>1 year after diagnosis
- Secondary Outcome Measures
Name Time Method To predict the prognosis of the diseaseTimepoint: O weeks <br/ ><br>2 weeks <br/ ><br>4 weeks <br/ ><br>6 weeks